+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johnson & Johnson Services, Inc. - logo

Johnson & Johnson has more than 250 companies located in 60 countries around the world. Their companies are broken down into several business segments: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson’s consumer healthcare segment produces a variety of consumer care products in the areas of baby care, skin and hair care, wound care, oral health, OTC medicines and nutritionals. Their medical devices segment produces a broad range of products used by healthcare professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics. The Janssen Pharmaceutical Companies of Johnson & Johnson are focused on oncology, immunology, neuroscience and infectious diseases, as well as cardiovascular and metabolic diseases. Their company headquarters are based in New Brunswick, New Jersey, USA.

Etravirine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Etravirine Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
From
From
From
From
From
From
From
Pancreatic Cancer Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pancreatic Cancer Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Kidney Cancer Drugs Market Report 2026 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cancer Biomarkers Market - Trends and Forecast Till 2035 - Product Thumbnail Image

Cancer Biomarkers Market - Trends and Forecast Till 2035

  • Report
  • October 2026
  • 336 Pages
  • Global
From
Transarterial Chemoembolization Market - Global Forecast 2026-2032 - Product Thumbnail Image

Transarterial Chemoembolization Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 191 Pages
  • Global
From
SGLT2 Inhibitors - Global Strategic Business Report 2026 - Product Thumbnail Image

SGLT2 Inhibitors - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 177 Pages
  • Global
From
From
Loading Indicator